Cosmo Bio Company,Limited
Tokyo Stock ExchangeTotal Valuation
Cosmo Bio Company,Limited carries a market capitalization of 7.24B, placing it among publicly traded companies globally.
| Market Cap | 7.24B |
| Enterprise Value | N/A |
Share Statistics
Cosmo Bio Company,Limited currently has 5.86M shares outstanding.
| Shares Outstanding | 5.86M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Cosmo Bio Company,Limited trades at a trailing price-to-earnings ratio of 17.97. The price-to-sales ratio is 0.63, and the price-to-book ratio stands at 0.88.
| PE Ratio | 17.97 |
| PS Ratio | 0.63 |
| PB Ratio | 0.88 |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Financial Position
Cosmo Bio Company,Limited maintains a current ratio of 7.36, meaning it holds 7.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 7.36 |
| Quick Ratio | 3.30 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 4.98 |
| Return on Assets (ROA) | 3.00 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 4.43 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 6.07 |
Taxes
Over the trailing twelve months, Cosmo Bio Company,Limited has paid 140.00M in income taxes, reflecting an effective tax rate of 28.51.
| Income Tax | 140.00M |
| Effective Tax Rate | 28.51 |
Stock Price Statistics
Cosmo Bio Company,Limited's stock has gained approximately 8.68085% over the past 52 weeks. The 50-day moving average sits at 1,241.64, while the 200-day moving average is 1,277.70.
| Beta (5Y) | N/A |
| 52-Week Price Change | 8.68085% |
| 50-Day Moving Average | 1,241.64 |
| 200-Day Moving Average | 1,277.70 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Cosmo Bio Company,Limited generated 9.64B in revenue and converted that into 339.00M in net income, yielding earnings per share of 60.15. EBITDA reached 384.00M, while operating income came in at 384.00M.
| Revenue | 9.64B |
| Gross Profit | 3.20B |
| Operating Income | 384.00M |
| Pretax Income | 491.00M |
| Net Income | 339.00M |
| EBITDA | 384.00M |
| EBIT | 384.00M |
| Earnings Per Share (EPS) | 60.15 |
Balance Sheet
Total book value stands at 6.89B, with working capital of 6.20B providing operational flexibility.
| Cash & Cash Equivalents | 3.22B |
| Total Debt | N/A |
| Net Debt | -3.00B |
| Equity (Book Value) | 6.89B |
| Book Value Per Share | 1,180.42 |
| Working Capital | 6.20B |
Margins
Cosmo Bio Company,Limited operates with a gross margin of 33.17, reflecting its pricing power and cost economics. The operating margin of 3.98 and net profit margin of 3.52 provide insight into operational efficiency.
| Gross Margin | 33.17 |
| Operating Margin | 3.98 |
| Pretax Margin | 5.09 |
| Profit Margin | 3.52 |
| EBITDA Margin | 3.98 |
Stock Splits
Cosmo Bio Company,Limited's most recent stock split took place on December 26, 2012 with a 1:100 split ratio.
| Last Split Date | 12/26/2012 |
| Split Ratio | 1:100 |
Scores
Cosmo Bio Company,Limited posts an Altman Z-Score of 4.18, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.18 |